CPP-Assisted Intracellular Drug Delivery, What Is Next?
AbstractFor the past 20 years, we have witnessed an unprecedented and, indeed, rather miraculous event of how cell-penetrating peptides (CPPs), the naturally originated penetrating enhancers, help overcome the membrane barrier that has hindered the access of bio-macromolecular compounds such as genes and proteins into cells, thereby denying their clinical potential to become potent anti-cancer drugs. By taking the advantage of the unique cell-translocation property of these short peptides, various payloads of proteins, nucleic acids, or even nanoparticle-based carriers were delivered into all cell types with unparalleled efficiency. However, non-specific CPP-mediated cell penetration into normal tissues can lead to widespread organ distribution of the payloads, thereby reducing the therapeutic efficacy of the drug and at the same time increasing the drug-induced toxic effects. In view of these challenges, we present herein a review of the new designs of CPP-linked vehicles and strategies to achieve highly effective yet less toxic chemotherapy in combating tumor oncology. View Full-Text
Share & Cite This Article
Ye, J.; Liu, E.; Yu, Z.; Pei, X.; Chen, S.; Zhang, P.; Shin, M.-C.; Gong, J.; He, H.; Yang, V.C. CPP-Assisted Intracellular Drug Delivery, What Is Next? Int. J. Mol. Sci. 2016, 17, 1892.
Ye J, Liu E, Yu Z, Pei X, Chen S, Zhang P, Shin M-C, Gong J, He H, Yang VC. CPP-Assisted Intracellular Drug Delivery, What Is Next? International Journal of Molecular Sciences. 2016; 17(11):1892.Chicago/Turabian Style
Ye, Junxiao; Liu, Ergang; Yu, Zhili; Pei, Xing; Chen, Sunhui; Zhang, Pengwei; Shin, Meong-Cheol; Gong, Junbo; He, Huining; Yang, Victor C. 2016. "CPP-Assisted Intracellular Drug Delivery, What Is Next?" Int. J. Mol. Sci. 17, no. 11: 1892.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.